A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression

Home » Studies » A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression

A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression

Study link https://pubmed.ncbi.nlm.nih.gov/29177955/

Health Goal Depression

Dietary Supplement Creatine

Study Level Randomized, Double Blind, Controlled Clinical Trial

A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression

Our Company

Knowledge Base